AU7994500A - Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1b gene - Google Patents

Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1b gene

Info

Publication number
AU7994500A
AU7994500A AU79945/00A AU7994500A AU7994500A AU 7994500 A AU7994500 A AU 7994500A AU 79945/00 A AU79945/00 A AU 79945/00A AU 7994500 A AU7994500 A AU 7994500A AU 7994500 A AU7994500 A AU 7994500A
Authority
AU
Australia
Prior art keywords
hydroxytryptamine
polymorphisms
serotonin
receptor
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU79945/00A
Inventor
Julie Y. Choi
Richard Rex Denton
Krishnan Nandabalan
Joel Claiborne Stephens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogenics Inc
Original Assignee
Genaissance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals Inc filed Critical Genaissance Pharmaceuticals Inc
Publication of AU7994500A publication Critical patent/AU7994500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/125—Allele specific primer extension
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU79945/00A 1999-10-07 2000-10-05 Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1b gene Abandoned AU7994500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15811499P 1999-10-07 1999-10-07
US60158114 1999-10-07
PCT/US2000/027486 WO2001025194A2 (en) 1999-10-07 2000-10-05 Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1b gene

Publications (1)

Publication Number Publication Date
AU7994500A true AU7994500A (en) 2001-05-10

Family

ID=22566738

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79945/00A Abandoned AU7994500A (en) 1999-10-07 2000-10-05 Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1b gene

Country Status (2)

Country Link
AU (1) AU7994500A (en)
WO (1) WO2001025194A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003012143A1 (en) * 2001-07-16 2003-02-13 Price Foundation Limited Genes and snps associated with eating disorders

Also Published As

Publication number Publication date
WO2001025194A3 (en) 2001-10-18
WO2001025194A2 (en) 2001-04-12

Similar Documents

Publication Publication Date Title
HK1044952A1 (en) N-pyrazole A2A receptor agonists n- A2A.
ZA200200298B (en) C-Pyrazole A2A receptor agonists.
AU4355500A (en) Determining the physical structure of subscriber lines
AU7445900A (en) Novel hemopoietin receptor protein, nr12
AU2925600A (en) Genetic screening
AU8457298A (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1H-indole derivatives interacting with the dopamine D4 receptor
IL148266A0 (en) Apo-2 receptor antibodies
AU1922801A (en) Genomic polymorphism for predicting therapeutic response
AU1738601A (en) Swellable delivery system
AU2001213316A8 (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1d gene
AU6110700A (en) Drug target isogenes: polymorphisms in the dopamine receptor d2 gene
AU7388700A (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine receptor 1a gene
AU2000263446A1 (en) Drug target isogenes: polymorphisms in the interleukin 4 receptor alpha gene
AU7994500A (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1b gene
AU1570701A (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1e gene
AU5143700A (en) Seven transmembrane receptor genes
AU2001213316A1 (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1d gene
AU6755300A (en) Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene
AU1081401A (en) Drug target isogenes: polymorphisms in the m1 muscarinic acetylcholine receptor gene
AU5016200A (en) Diabetes gene
AU6343400A (en) Drug target isogenes: polymorphisms in the osteoclastogenesis inhibitory factor gene
AU1773501A (en) Human single nucleotide polymorphisms
AU3269401A (en) Simultaneous hybridization/priming for snp analysis
AU6612700A (en) Drug target isogenes: polymorphisms in the solute carrier family 6 neurotransmitter transporter, serotonin , member gene
AU1338901A (en) Drug target isogenes: polymorphisms in the cholinergic receptor, muscarinic 5 gene

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase